Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/11801
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWen, Shu Wenen
dc.contributor.authorAger, Eleanor Ien
dc.contributor.authorChristophi, Christopheren
dc.date.accessioned2015-05-16T01:25:45Z
dc.date.available2015-05-16T01:25:45Z
dc.date.issued2013-05-10en
dc.identifier.citationCancer Biology & Therapy 2013; 14(7): 606-13en
dc.identifier.govdoc23792646en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/11801en
dc.description.abstractKupffer cells (KCs) are resident liver macrophages that play a crucial role in liver homeostasis and in the pathogenesis of liver disease. Evidence suggests KCs have both stimulatory and inhibitory functions during tumor development but the extent of these functions remains to be defined. Using KC depletion studies in an orthotopic murine model of colorectal cancer (CRC) liver metastases we demonstrated the bimodal role of KCs in determining tumor growth. KC depletion with gadolinium chloride before tumor induction was associated with an increased tumor burden during the exponential growth phase. In contrast, KC depletion at the late stage of tumor growth (day 18) decreased liver tumor load compared with non-depleted animals. This suggests KCs exhibit an early inhibitory and a later stimulatory effect. These two opposing functions were associated with changes in iNOS and VEGF expression as well as T-cell infiltration. KC depletion at day 18 increased numbers of CD3 (+) T cells and iNOS-expressing infiltrating cells in the tumor, but decreased the number of VEGF-expressing infiltrating cells. These alterations may be responsible for the observed reduction in tumor burden following depletion of pro-tumor KCs at the late stage of metastatic growth. Taken together, our results indicate that the bimodal role of KC activity in liver tumors may provide the key to timing immunomodulatory intervention for the treatment of CRC liver metastases.en
dc.language.isoenen
dc.subject.otherKupffer cellen
dc.subject.othercolorectal canceren
dc.subject.otherliver metastasesen
dc.subject.othermacrophageen
dc.subject.othertumor-associated macrophagesen
dc.subject.otherAnimalsen
dc.subject.otherColorectal Neoplasms.metabolism.pathologyen
dc.subject.otherHumansen
dc.subject.otherKupffer Cells.metabolism.pathologyen
dc.subject.otherLiver Neoplasms, Experimental.metabolism.pathology.secondaryen
dc.subject.otherMiceen
dc.subject.otherNeoplasm Metastasisen
dc.titleBimodal role of Kupffer cells during colorectal cancer liver metastasis.en
dc.typeJournal Articleen
dc.identifier.journaltitleCancer biology & therapyen
dc.identifier.affiliationShuWen.Wen@qimr.edu.auen
dc.identifier.affiliationDepartment of Surgery, The University of Melbourne, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.doi10.4161/cbt.24593en
dc.description.pages606-13en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/23792646en
dc.type.austinJournal Articleen
local.name.researcherChristophi, Christopher
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.languageiso639-1en-
crisitem.author.deptSurgery-
crisitem.author.deptHepatopancreatobiliary Surgery-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

38
checked on Dec 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.